Ignite Creation Date:
2025-12-26 @ 11:48 AM
Ignite Modification Date:
2026-03-01 @ 9:45 AM
Study NCT ID:
NCT02990416
Status:
UNKNOWN
Last Update Posted:
2016-12-13
First Post:
2016-11-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma
Sponsor:
Angimmune LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01
Start Date Type:
None
Primary Completion Date:
2018-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-06
Completion Date Type:
ESTIMATED
First Submit Date:
2016-11-28
First Submit QC Date:
None
Study First Post Date:
2016-12-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-12-12
Last Update Post Date:
2016-12-13
Last Update Post Date Type:
ESTIMATED